Making the Call in Heart Failure:

This activity is jointly provided by Global Education Group and Integritas Communications. 

This activity is supported by an educational grant from AstraZeneca.

This event is not part of the official Scientific Sessions Conference 2022 as planned by the AHA Committee on Scientific Sessions Programming.

Target Audience

The educational design of this activity addresses the needs of cardiologists and other specialist clinicians with a focus on heart failure.

Learning Objectives

Upon completion of this activity, the participant should be better able to:

• Evaluate patients with heart failure based on new consensus recommendations for definition, staging, and classification
• Discuss the clinical profiles, trial designs, and recent data for SGLT-2 inhibitors in patients with HFrEF or HFpEF, including cardiovascular and renal outcomes
• Incorporate SGLT-2 inhibitors into treatment algorithms for heart failure to reflect appropriate patient selection, safety considerations, and prescribing recommendations
• Individualize treatment regimens for patients with heart failure with consideration of case presentation, practice guidelines, newly published evidence, and comorbidities, such as CKD
   

Program Overview

Heart failure medicine is dynamic, with recent approvals for use of SGLT2 inhibitors, and updated recommendations for definition, staging, and classification of heart failure. As heart failure therapies overlap into other specialties, it is more important than ever to use a patient-centered, multidisciplinary care team model. In this 90-minute Call-a-Colleague presentation, three experts will discuss the new consensus recommendations for heart failure and the evidence for using SGLT2 inhibitors in patients with different classes of heart failure as well as comorbidities. To illustrate how to individualize treatment regimens and the nuances of heart failure care, they will call in specialist colleagues for consults about practical considerations for prescribing SGLT2 inhibitors.

Agenda

• Preactivity Questionnaire and Faculty Introductions
• Overview of New Heart Failure Recommendations from 2022 AHA/ACC/HFSA Guideline for the Management of  Heart Failure
• Pathophysiology of Heart Failure - Insights Into the Mechanism of SGLT2 Inhibitors
• Panel Discussion - Data on SGLT2 Inhibitors in Heart Failure
• Renoprotective Outcomes from Large Clinical Trials with SGLT2 Inhibitors
• Pulling Things Together: Comprehensive Management of Patients with Heart Failure
• Postactivity Questionnaire and Q&A Session

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.

* This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Global adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited Continuing Education (CE), set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

Global Contact Information

For information about the approval of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Mara Simpson prior to the live event at msimpson@integritasgrp.com.